MedPath

NIDAGEL

NIDAGEL

Approved
DIN Number

02125226

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

bausch health, canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02125226
AIG Number0102572005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G01AF01 METRONIDAZOLE
Product Specifications
Dosage FormGel
Route of AdministrationVaginal
AHFS Classification84:04.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

METRONIDAZOLEActive
Strength: 0.75 % / W/W
Monograph: METRONIDAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.